(MENAFN- GlobeNewsWire - Nasdaq) Growing Adoption of Directional Leads, Closed-Loop Stimulation Systems, and Personalized Neuromodulation Therapies Accelerating Market Expansion.Austin, United States, March 11, 2026 (GLOBE NEWSWIRE) -- Deep Brain Stimulation Devices Market Size & Growth Analysis:
According to SNS Insider, The Deep Brain Stimulation Devices Market size is estimated at USD 1.54 billion in 2025 and is expected to reach USD 4.43 billion by 2035, growing at a CAGR of 11.12% over 2026-2035. The growth of the market is driven by increasing prevalence of neurological disorders, technological advancements in minimally invasive surgical procedures, and expanding clinical applications beyond traditional movement disorders.
Market Size and Forecast:
Market Size in 2025: USD 1.54 billion Market Size by 2035: USD 4.43 billion CAGR: 11.12% from 2026 to 2035 Base Year: 2025 Forecast Period: 2026–2035 Historical Data: 2022–2024
Get a Sample Report of Deep Brain Stimulation Devices Market:
The U.S. Deep Brain Stimulation Devices Market is estimated at USD 0.62 billion in 2025 and is expected to reach USD 1.78 billion by 2035, growing at a CAGR of 11.18% over 2026-2035. Due to its sophisticated neurosurgical infrastructure, high rates of Parkinson's disease and essential tremor, and sophisticated healthcare reimbursement systems, the United States is the largest market for deep brain stimulation devices.
Rising Prevalence of Neurological Disorders and Aging Population is Augmenting Market Expansion Globally
The growing incidence of Parkinson's disease, essential tremor, dystonia, and epilepsy among older populations in need of advanced neuromodulation therapies are the main factors driving the market share of deep brain stimulation devices. The market base, single-channel and dual-channel market penetration, and global market share are all being driven by these treatments for mental diseases and medication-resistant movement disorders.
High Device Costs and Limited Reimbursement Coverage May Hinder Market Expansion Globally
The market for deep brain stimulation devices is also constrained by high device costs and limited reimbursement coverage because many patients cannot afford neurostimulation treatments, and healthcare systems are burdened by high implantation and replacement costs. Treatment delays, restricted market penetration, and decreased patient access in poorer nations could result from this. As a result, in areas with inadequate healthcare infrastructure and a lack of neurosurgical knowledge, patient outcomes deteriorate and market growth is slowed.
Major Players Listed in this Report:
Medtronic plc Boston Scientific Corporation Abbott Laboratories NeuroPace, Inc. Aleva Neurotherapeutics Functional Neuromodulation Ltd. Beijing PINS Medical Co., Ltd. SceneRay Corporation Limited Neuronetics, Inc. LivaNova PLC Nevro Corp. Integer Holdings Corporation Synapse Biomedical Inc. Renishaw plc Stryker Corporation Alpha Omega Engineering MicroProbes for Life Science DIXI Medical NDI Medical LLC NeuroNexus Technologies
Segmentation Analysis:
By Product
The dual channel segment accounted for the highest revenue share of approximately 63.47% in 2025, owing to superior bilateral symptom control capabilities and comprehensive therapeutic coverage for bilateral movement disorders globally. The single channel segment is anticipated to achieve the highest CAGR of nearly 11.45% during the 2026–2035 period, driven by the increasing demand from cost-conscious healthcare systems and lower device complexity reducing surgical time globally.
By Application
By 2025, the Parkinson's disease segment contributed the largest revenue share of 41.28% due to established clinical efficacy, extensive long-term safety data and widespread regulatory approvals for motor symptom management. The depression segment is projected to grow at the highest CAGR of about 13.87% between 2026 and 2035 due to the growing need for treatment-resistant depression therapies and expanding clinical trial evidence base.
By End-Use
The hospitals segment accounted for the largest share of the deep brain stimulation devices market with about 54.36%, owing to their comprehensive neurosurgical capabilities globally. The segment is also expected to grow at the fastest rate with a CAGR of around 11.34% throughout the forecast period of 2026–2035, as hospital systems expand neurology service lines and academic medical centers lead clinical innovation globally.
For a Personalized Briefing with Our Industry Analysts, Connect Now:
Deep Brain Stimulation Devices Market Segmentation
By Product
Single Channel Dual Channel
By Application
Pain Management Epilepsy Essential Tremor Obsessive Compulsive Disorder (OCD) Depression Dystonia Parkinson's Disease Others
By End-Use
Hospitals Neurology Clinics Ambulatory Surgical Centers Research Centers
Regional Insights:
Asia Pacific is the fastest-growing segment in the deep brain stimulation devices market with a CAGR of 12.67%, as the awareness about advanced neurosurgical treatments, government healthcare modernization initiatives, and neurology infrastructure development in developing nations is growing.
North America held the largest revenue share of over 42.18% in 2025 of the deep brain stimulation devices market due to an established neurosurgical infrastructure, comprehensive insurance reimbursement frameworks, and increased patient awareness regarding the benefits of neuromodulation therapies.
Recent Developments:
In February 2025, Medtronic plc expanded its Percept PC deep brain stimulation system capabilities with enhanced BrainSense technology and personalized therapy optimization features, aiming to improve symptom control and adaptive stimulation delivery across its global patient network. In May 2024, Boston Scientific Corporation launched an enhanced Vercise Genus deep brain stimulation system featuring multiple independent current control and extended battery longevity across North American and European markets, enhancing programming flexibility, therapy precision, and device replacement interval extension.
Exclusive Sections of the Report (The USPs):
DEVICE IMPLANTATION & PATIENT ADOPTION METRICS – helps you analyze global deep brain stimulation implantation volumes, patient demographics at the time of surgery, surgical success rates, and patient satisfaction levels reflecting quality-of-life improvements after DBS therapy. TECHNOLOGY INNOVATION & DEVICE EVOLUTION METRICS – helps you evaluate adoption trends of rechargeable versus primary cell battery systems, penetration of directional lead technology, and the growing implementation of sensing-enabled DBS devices and wireless programming capabilities. CLINICAL EFFICACY & OUTCOMES METRICS – helps you understand treatment effectiveness through indicators such as motor symptom improvement rates, medication reduction percentages following implantation, device-related adverse events, and long-term device performance. MARKET ACCESS & REIMBURSEMENT METRICS – helps you assess insurance coverage trends across key regions, reimbursement levels for DBS procedures, patient out-of-pocket cost burdens, and overall healthcare economic impact of DBS therapy. SUPPLY CHAIN & DEVICE AVAILABILITY ANALYSIS – helps you identify production scalability, distribution efficiency, and supply chain reliability for DBS systems across hospitals, neurology centers, and specialized surgical facilities globally. COMPETITIVE LANDSCAPE – helps you gauge the competitive strength of key players in the deep brain stimulation devices market through analysis of their product portfolios, innovation pipelines, geographic reach, and recent strategic developments.
Deep Brain Stimulation Devices Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 1.54 Billion |
| Market Size by 2035 | USD 4.43 Billion |
| CAGR | CAGR of 11.12% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Purchase Single User PDF of Deep Brain Stimulation Devices Market Report (20% Discount):
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Market Overview
4. Statistical Insights & Trends Reporting
5. Deep Brain Stimulation Devices Market Segmental Analysis & Forecast, By Product
6. Deep Brain Stimulation Devices Market Segmental Analysis & Forecast, By Application
7. Deep Brain Stimulation Devices Market Segmental Analysis & Forecast, By End-Use
8. Deep Brain Stimulation Devices Market Segmental Analysis & Forecast, By Region
9. Competitive Landscape
10. Analyst Recommendations
11. Assumptions
12. Disclaimer
13. Appendix
Access Complete Report Details of Deep Brain Stimulation Devices Market Analysis & Outlook:
[For more information or need any customization research mail us at...]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email:...
![]()
MENAFN11032026004107003653ID1110847362
Comments
No comment